NO970513L - Urokinase-reseptorligander - Google Patents

Urokinase-reseptorligander

Info

Publication number
NO970513L
NO970513L NO970513A NO970513A NO970513L NO 970513 L NO970513 L NO 970513L NO 970513 A NO970513 A NO 970513A NO 970513 A NO970513 A NO 970513A NO 970513 L NO970513 L NO 970513L
Authority
NO
Norway
Prior art keywords
aryl
alkyl
aralkyl
halogen
independently
Prior art date
Application number
NO970513A
Other languages
English (en)
Norwegian (no)
Other versions
NO970513D0 (no
Inventor
Steve Rosenberg
Kerry L Spear
Eric J Martin
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of NO970513D0 publication Critical patent/NO970513D0/no
Publication of NO970513L publication Critical patent/NO970513L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO970513A 1995-06-07 1997-02-05 Urokinase-reseptorligander NO970513L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/485,021 US5747458A (en) 1995-06-07 1995-06-07 Urokinase receptor ligands
PCT/US1996/009648 WO1996040747A1 (en) 1995-06-07 1996-06-06 Urokinase receptor ligands

Publications (2)

Publication Number Publication Date
NO970513D0 NO970513D0 (no) 1997-02-05
NO970513L true NO970513L (no) 1997-02-05

Family

ID=23926620

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970513A NO970513L (no) 1995-06-07 1997-02-05 Urokinase-reseptorligander

Country Status (14)

Country Link
US (2) US5747458A (de)
EP (1) EP0777680B1 (de)
JP (1) JPH10503784A (de)
AT (1) ATE214711T1 (de)
AU (1) AU6164096A (de)
BR (1) BR9606429A (de)
CA (1) CA2196334A1 (de)
DE (1) DE69619940T2 (de)
FI (1) FI970446A7 (de)
HU (1) HUP9702220A3 (de)
IL (1) IL120101A0 (de)
MX (1) MX9700888A (de)
NO (1) NO970513L (de)
WO (1) WO1996040747A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519120A (en) * 1989-04-07 1996-05-21 Cancerforskningsfondet Af 1989 Urokinase-type plasminogen activator receptor antibodies
ID24525A (id) * 1997-07-31 2000-07-20 Hoffmann La Roche Turunan-turunan hidroksikumaranon tersubstitusi-0 sebagai zat anti tumor dan zat antimetastatik
WO1999055688A1 (en) * 1998-04-27 1999-11-04 Warner-Lambert Company Substituted diarylalkyl amides as calcium channel antagonists
US6228985B1 (en) 1998-05-21 2001-05-08 Schering Corporation Derivatives of aminobenzoic and aminobiphenylcarboxylic acids useful as anti-cancer agents
ES2169690B1 (es) * 2000-10-06 2004-03-16 Diverdrugs Sl Trimeros de n-alquilglicina capaces de proteger a neuronas contra agresiones excitotoxicas, y composiciones que los contienen.
ES2169691B1 (es) * 2000-10-11 2004-03-16 Diverdrugs Sl Trimeros de n-alquilglicina capaces de bloquear la respuesta a sustancias quimicas, estimulos termicos o mediadores de la inflamacion de receptores neuronales, y composiciones que los contienen.
CA2522203A1 (en) * 2003-04-15 2004-10-28 Gema Tarrason Identification of n-alkylglycine trimers for induction of apoptosis
CN103270022B (zh) 2010-08-31 2015-08-19 巴勃罗·比咯斯拉达 神经营养蛋白受体激动剂及其作为药物的应用
EP2647622B1 (de) * 2010-12-03 2017-04-19 Fujitsu Limited Kinesinspindelproteinhemmer sowie ihre verwendung
IT202100023357A1 (it) 2021-09-09 2023-03-09 Cheirontech S R L Peptidi con attività anti-angiogenica

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247080A (en) * 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
WO1986000991A1 (en) * 1984-07-24 1986-02-13 Commonwealth Serum Laboratories Commission Method for determining mimotopes
NZ215865A (en) * 1985-04-22 1988-10-28 Commw Serum Lab Commission Method of determining the active site of a receptor-binding analogue
IE66205B1 (en) * 1990-06-14 1995-12-13 Paul A Bartlett Polypeptide analogs
PL308204A1 (en) * 1992-09-24 1995-07-24 Chiron Corp Synthesis of n-substituted oligomers
US5536853A (en) * 1994-04-11 1996-07-16 Chiron Corporation Opiate receptor ligands
ZA953361B (en) * 1994-04-26 1996-01-12 Selectide Corp Factor Xa inhibitors

Also Published As

Publication number Publication date
DE69619940T2 (de) 2002-12-19
WO1996040747A1 (en) 1996-12-19
BR9606429A (pt) 1997-09-02
HUP9702220A2 (hu) 1998-05-28
EP0777680B1 (de) 2002-03-20
FI970446L (fi) 1997-03-26
JPH10503784A (ja) 1998-04-07
NO970513D0 (no) 1997-02-05
CA2196334A1 (en) 1996-12-19
IL120101A0 (en) 1997-04-15
EP0777680A1 (de) 1997-06-11
FI970446A0 (fi) 1997-02-03
MX9700888A (es) 1997-04-30
AU6164096A (en) 1996-12-30
HUP9702220A3 (en) 1998-06-29
DE69619940D1 (de) 2002-04-25
US5747458A (en) 1998-05-05
US6121240A (en) 2000-09-19
FI970446A7 (fi) 1997-03-26
ATE214711T1 (de) 2002-04-15

Similar Documents

Publication Publication Date Title
CA2116967A1 (en) Antidepressants
CA2131797A1 (en) Condensed indole derivatives as 5ht4-receptor antagonists
NO20065929L (no) Sykliske amidderivater, deres fremstilling og anvendelse
MX9709951A (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
NO20030471L (no) Karboksamidforbindelser og deres anvendelse som antagonister for en 11CBY-reseptor
CA2107014A1 (en) Therapeutic Agent for Parkinson's Disease
PE20040155A1 (es) Derivados aminoinazoles, procedimiento de preparacion e intermedios de este procedimiento a titulo de medicamentos y composiciones farmaceuticas que los contienen
MY114679A (en) Aroyl-piperidine derivatives
DE69310501D1 (de) Chinolylbenzofuran derivate als leukotrien-antagonisten
NO20020725L (no) Celleadhesjonsinhibitorer
DE69433984D1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
PL351878A1 (en) Amino compound derivatives
DE69622246D1 (de) Neue Naphthamid-Derivate und ihre therapeutische Verwendung als D3-Rezeptor Agonisten
NO20045351L (no) 1-[(indol-3-yl)karbonyl] piperazin-derivater
AR015964A1 (es) Compuestos de isoquinolina, su uso, procedimiento para tratar una afeccion, procedimiento de preparacion del compuesto, composicion farmaceutica que locontiene y compuesto util en dicho procedimiento
KR890016017A (ko) 치환된 1-(1h-이미다졸-4-일)알킬-벤즈아미드
AU2003207808A1 (en) Peroxisome proliferator activated receptor modulators
EP1798227A4 (de) Agonist des serotonin-5-ht3-rezeptors
ATE214711T1 (de) Liganden des urokinaserezeptors
DK0612314T3 (da) 2-pyrazinylethylaminderivater og deres anvendelse som lægemidler
HUP9802568A2 (hu) Glutamát-receptor antagonista hatású szubsztituált-kinoxalin-2,3-dionok alkil-amin-származékai és ezeket tartalmazó gyógyszerkészítmények
GB1420067A (en) Aryldiamides
DE69813886D1 (de) Naphthalin derivate
MXPA05012096A (es) Derivados de amina ciclica, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
KR940005475A (ko) 3- 아미노에틸 인돌로부터 유도되는 아미딘 및 이의 제조방법